151 related articles for article (PubMed ID: 1464278)
1. Possible interaction between oxcarbazepine and an oral contraceptive.
Klosterskov Jensen P; Saano V; Haring P; Svenstrup B; Menge GP
Epilepsia; 1992; 33(6):1149-52. PubMed ID: 1464278
[TBL] [Abstract][Full Text] [Related]
2. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women.
Fattore C; Cipolla G; Gatti G; Limido GL; Sturm Y; Bernasconi C; Perucca E
Epilepsia; 1999 Jun; 40(6):783-7. PubMed ID: 10368079
[TBL] [Abstract][Full Text] [Related]
3. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
Kuhnz W; al-Yacoub G
Horm Res; 1991; 35(5):178-81. PubMed ID: 1802819
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
7. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
Abdalla KA; Shabaan MM; Stanczyk FZ
Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
[TBL] [Abstract][Full Text] [Related]
8. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole does not affect the bioavailability of oral contraceptives.
Fuchs W; Sennewald R; Klotz U
Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
[TBL] [Abstract][Full Text] [Related]
10. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
14. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
Heger-Mahn D; Pabst G; Dienel A; Schläfke S; Klipping C
Drugs R D; 2014 Dec; 14(4):265-72. PubMed ID: 25319228
[TBL] [Abstract][Full Text] [Related]
15. The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy.
Grimmer SF; Back DJ; Orme ML; Cowie A; Gilmore I; Tjia J
Contraception; 1986 Jan; 33(1):51-9. PubMed ID: 3082591
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
Leis D; Botterman P; Ermler R; Maurer U
Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
[TBL] [Abstract][Full Text] [Related]
17. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives, lipoproteins, and atherosclerosis.
Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
[TBL] [Abstract][Full Text] [Related]
19. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and biological justifications for the use of Triella].
McGuire JL; Pasquale SA; Castaigne JP
Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
